Mylan quarterly profit, 2019 forecast miss Wall Street estimates — stock tanks

Generic drugmaker Mylan on Tuesday reported lower-than-expected fourth-quarter profit and forecast 2019 earnings well below Wall Street estimates, as it grapples with significant problems at its Morgantown, West Virginia, plant. Health and Science U.S.HEALTHCARE UPDATE: Click today to request your … Read more…

The worst-performing Dow stock this year is about to report earnings. Here’s what to expect

Ari Wald of Oppenheimer and Gina Sanchez of Chantico Global discuss Pfizer shares before the company's earnings are released with CNBC's Mike Santoli. Health and Science U.S.HEALTHCARE UPDATE: Click today to request your free ACRX discount prescription card and save … Read more…

Sen. James Inhofe Bought Defense Stock Days After Pushing For Record Pentagon Spending—Then Dumped It When Asked About It

Chip Somodevilla/Getty Just days after signaling his support for unprecedented levels of U.S. defense spending, Sen. James Inhofe (R-OK), the chairman of the Senate Armed Services Committee, reported purchasing tens of thousands of dollars of stock in one of the … Read more…